Royal DSM NV has entered the growing market of human milk oligosaccharides (HMO) taking over the producer of recombinant 2′-fucosyl lactose, Danish Glycom A/S.
Shortly before a EU health ministers discuss the spread of the Chinese coronavirus, EU diagnostic labs have considered themselves prepared for a possible Sars-CoV-2 epidemic.
Co-founder Fiona Withey is the new Chief Executive Officer of TrakCel, a software developer of orchestration systems for advanced therapies. Co-founder Ravi Nalliah was appointed to the role of Chief Strategy Officer.
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00Michael Kuhrt/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMichael Kuhrt2020-02-18 08:50:002020-02-18 08:50:00TrakCel: New at the helm
Applied Photophysics Limited, active in biophysical characterization of biomolecules, has appointed Tim Flanagan as Chief Executive Officer and member of the Board of Directors.
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2020-02-17_um_09.39.26.png283393Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-02-17 08:39:342020-02-17 08:39:34PharmaMar/Jazz Pharmaceuticals get NDA priority for lung cancer drug
Using a combination of approved diabetes drugs, a Swiss-US research team was able to support the regeneration of insulin-secreting cells in the pancreas.
Researchers report that JAK inhibitors – a class of approved anti-inflammatory drugs – prevented bone loss in mice with osteoporosis and two patients with rheumatoid arthritis.
https://european-biotechnology.com/wp-content/uploads/2024/04/rodent-3177373_1280.jpg9971280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-02-13 10:26:222020-02-13 10:26:22JAKPot for treating bone loss
Post-Brexit budget drives cuts in Horizon Europe
Latest NewsNegotiations of the EU Council on the EU’s seven-year budget have failed, putting R&D funding at risk for significant cuts.
Royal DSM acquires Glycom A/S for €765m
Latest NewsRoyal DSM NV has entered the growing market of human milk oligosaccharides (HMO) taking over the producer of recombinant 2′-fucosyl lactose, Danish Glycom A/S.
Immatics Biotechnologies lands €1.1bn deal with GSK
Latest NewsUS-German immunooncology specialist Immatics Biotechnologies GmbH has licensed two of its TCR-T programs to GlaxoSmithKline for US$50m upfront.
KKR backs Belgian tech provider Univercells SA
Latest NewsUnivercells S.A. cashes in up to €50m from the KKR subsidiary Gamma Bioscience to advance its gene and cell therapy manufacturing platform.
EU diagnostic labs prepared for Sars-CoV-2
Latest NewsShortly before a EU health ministers discuss the spread of the Chinese coronavirus, EU diagnostic labs have considered themselves prepared for a possible Sars-CoV-2 epidemic.
TrakCel: New at the helm
AppointmentsCo-founder Fiona Withey is the new Chief Executive Officer of TrakCel, a software developer of orchestration systems for advanced therapies. Co-founder Ravi Nalliah was appointed to the role of Chief Strategy Officer.
Applied Photophysics: Permanent head
AppointmentsApplied Photophysics Limited, active in biophysical characterization of biomolecules, has appointed Tim Flanagan as Chief Executive Officer and member of the Board of Directors.
PharmaMar/Jazz Pharmaceuticals get NDA priority for lung cancer drug
Latest NewsDiabetes combo improves regeneration of beta cells
Latest NewsUsing a combination of approved diabetes drugs, a Swiss-US research team was able to support the regeneration of insulin-secreting cells in the pancreas.
JAKPot for treating bone loss
Latest NewsResearchers report that JAK inhibitors – a class of approved anti-inflammatory drugs – prevented bone loss in mice with osteoporosis and two patients with rheumatoid arthritis.